Global Surgical Dressing Market 2023-2030

Global Surgical Dressing Market 2023-2030

Global Surgical Dressing Market Size, Share & Trends Analysis Report by Type (Collagen Dressings, Transparent Film Dressings, Alginate Dressings, Foam Dressings, Gauze Dressings, Silver Dressings, and Others), by Application (Cardiovascular Diseases (CVD), Diabetes Based Surgeries, Transplant Sites, Ulcers, and Burns), and by End-User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Home Healthcare) Forecast Period (2023-2030)

The global surgical dressing market is anticipated to grow at a CAGR of 6.4% during the forecast period (2023-2030). The prevalence of chronic wounds, such as venous leg ulcers, pressure ulcers, and diabetic foot ulcers, is increasing challenges to wound care professionals, having a considerable impact on the growth of the surgical dressing industry. According to the Centers for Disease Control and Prevention (CDC), more than 37 million Americans have diabetes, and another 96 million adults in the US have a condition called prediabetes, which puts them at risk for type 2 diabetes. About 25% of individuals with diabetes mellitus have poor wound healing, which can lead to the removal of lower limbs and has significant financial and psychological consequences. The hyperglycemic environment encourages the growth of biofilms and makes it challenging to treat diabetic wounds. Diabetes can cause serious complications, including heart disease, kidney failure, and blindness. In October 2022, according to the report published by the Australian Department of Health and Aged Care, the department made a targeted investment of $1.20 million over three years from 2019-2021 for wound management. Chronic wounds are a significant problem in Australia, with an estimated 400,000 cases in hospital and residential care settings yearly.

Furthermore, according to the National Institute of Health (NIH), chronic non-healing wounds (CNHW) are typically correlated with comorbidities such as diabetes, vascular deficits, hypertension, and chronic kidney disease. The result has increased the demand for surgical dressing. Furthermore, the rising number of food and drug administration (FDA) clearance also attributed to the increasing adoption of surgical dressing. In April 2023, 3M Health Care's innovative 3M™ Veraflo™ Therapy, with both 3M™ Veraflo™ Cleanse Choice Complete™ Dressing and 3M™ V.A.C. Veraflo Cleanse Choice™ Dressing, received the first-ever Food and Drug Administration (FDA) clearance for hydromechanical removal of infectious materials, non-viable tissue and wound debris which reduces the number of surgical debridement required, while promoting granulation tissue formation, creating an environment that promotes wound healing.

Segmental Outlook

The global surgical dressing market is segmented on the type, application, and end-user. Based on the type, the market is sub-segmented into collagen dressings, transparent film dressings, alginate dressings, foam dressings, gauze dressings, silver dressings, and others. Further, other types of surgical dressing include hydrogel dressings, composites dressings. Based on the application, the market is sub-segmented into cardiovascular diseases, diabetes-based surgeries, transplant sites, ulcers, and burns. Further, based on the end-user, the market is sub-segmented into hospitals, ambulatory surgery centers, specialty clinics and home healthcare. Among the type, the transparent film dressings sub-segment is anticipated to hold a considerable share of the market, owing to the maintaining wound moisture and reducing infection rates.

The Hospitals Sub-Segment is Anticipated to Hold a Considerable Share of the Global Surgical Dressing Market

Among the end-user, the hospitals sub-segment is expected to hold a considerable share of the global surgical dressing market. The segmental growth is attributed to the growing number of surgical procedures, increasing occurrence of diabetic foot ulcers, and rising number of hospitals. Hospitals provide services such as admitted patient care, including for elective surgery, emergency department care, and outpatient (non-admitted patient) care. As per the latest survey by the American Hospital Association (AH), the total number of hospitals in the US was counted ware 6,129 in 2023. Moreover, according to the Australian Institute of Health and Welfare, the number of hospitalizations in Australia has increased. In In 2021–22, there were 11.6 million hospitalizations, covering 31.8 million days of patient care, 59.0% (6.8 million) of hospitalizations were in public hospitals, accounting for 68.0.% of days of patient care (21.7 million). There are 41.0% (4.8 million) of hospitalizations were in private hospitals, accounting for 32.0% of days of patient care (10.0 million). Thus, with a growing number of hospitals, and hospitalization cases, the segment is projected to grow significantly over the forecast period.

Regional Outlook

The global surgical dressing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, owing to the increasing prevalence of diabetes, increasing R&D and growing medical tourism industry.

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Surgical Dressing Market

Among all regions, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period. China dominates the Asia-Pacific surgical dressing market followed by India, Japan, South Korea, and the rest of the Asia-Pacific economies. The surgical dressing market in China is experiencing growth owing to rising number of surgeries, rising number of cardiovascular disease-related surgeries, and increasing prevalence of chronic disorders, such as diabetes. According to the World Health Organization, China has the highest number of diabetic patients globally, with nearly 116 million active cases in 2019, and is expected to increase to 150 million by 2040. The estimated diabetes prevalence rate in China in 2009 was 3.9% and is projected to increase to 5.4% by 2030. The prevalence of diabetes in Chinese adults aged 20-79 years is projected to increase from 8.2% to 9.7% during 2020-2030. The expansion and emergence of the wound care management sector by Chinese players such as Winner Medical, Covalon, and others contribute to the market’s growth. For instance, in June 2022, Winner Medical displayed its latest and industry-leading advanced wound care solutions at the EWMA 2022 conference. At the conference, Winner Medical also launched a new product such as transparent film dressing, bordered silicone foam dressing with SAF and antibiosis series products and its new product, the CMC dressing. Winner Medical's wound care products have been widely used in more than 110 countries as primary solutions to provide wound management for acute and chronic wounds resulting from diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes.

Market Players Outlook

The major companies serving the global surgical dressing market include 3M Co., ConvaTec Group Plc, Johnson & Johnson Services, Inc., Smith & Nephew Plc, Abigo Medical AB, B. Braun SE, Baxter Healthcare Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2022, Convatec Group Plc, a global medical solutions company focused on the management of chronic conditions, entered into a definitive agreement to acquire Triad Life Sciences Inc., a US-focused medical device company that develops biologically derived innovative products to address unmet clinical needs in surgical wounds, chronic wounds and burns.

The Report Covers

Market value data analysis of 2022 and forecast to 2030.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global surgical dressing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market-entry and market expansion strategies.

Competitive strategies by identifying ‘who-stands-where’ in the market.